BONEH Stock Overview
BBS-Bioactive Bone Substitutes Oyj, a biomedical technology company, develops, manufactures, and commercializes bioactive medical devices and implants for orthopedic surgery in Finland.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
BBS-Bioactive Bone Substitutes Oyj Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.46 |
| 52 Week High | €1.10 |
| 52 Week Low | €0.38 |
| Beta | -0.51 |
| 1 Month Change | -1.07% |
| 3 Month Change | -6.46% |
| 1 Year Change | -47.39% |
| 3 Year Change | -84.20% |
| 5 Year Change | -83.70% |
| Change since IPO | -89.23% |
Recent News & Updates
Recent updates
We Think BBS-Bioactive Bone Substitutes Oyj (HEL:BONEH) Has A Fair Chunk Of Debt
Sep 16
BBS-Bioactive Bone Substitutes Oyj (HEL:BONEH) Is Making Moderate Use Of Debt
Dec 20BBS-Bioactive Bone Substitutes Oyj (HEL:BONEH) Is Making Moderate Use Of Debt
Sep 02Is BBS-Bioactive Bone Substitutes Oyj (HEL:BONEH) Using Too Much Debt?
Feb 27Shareholder Returns
| BONEH | FI Biotechs | FI Market | |
|---|---|---|---|
| 7D | -4.1% | 0.3% | -0.8% |
| 1Y | -47.4% | -11.3% | -14.0% |
Return vs Industry: BONEH underperformed the Finnish Biotechs industry which returned -11.3% over the past year.
Return vs Market: BONEH underperformed the Finnish Market which returned -14% over the past year.
Price Volatility
| BONEH volatility | |
|---|---|
| BONEH Average Weekly Movement | 7.4% |
| Biotechs Industry Average Movement | 7.3% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in FI Market | 8.1% |
| 10% least volatile stocks in FI Market | 3.2% |
Stable Share Price: BONEH's share price has been volatile over the past 3 months.
Volatility Over Time: BONEH's weekly volatility has decreased from 13% to 7% over the past year, but is still higher than 75% of Finnish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1991 | 20 | Juliusz Rakowskias | www.bbs-artebone.fi |
BBS-Bioactive Bone Substitutes Oyj, a biomedical technology company, develops, manufactures, and commercializes bioactive medical devices and implants for orthopedic surgery in Finland. It offers ARTEBONE, an orthobiological product based on tricalcium phosphate and natural spectrum of bone proteins used primarily for the treatment of bone defects and healing problems in extremities, such as foot and ankle. The company was incorporated in 1991 and is headquartered in Oulu, Finland.
BBS-Bioactive Bone Substitutes Oyj Fundamentals Summary
| BONEH fundamental statistics | |
|---|---|
| Market cap | €8.93m |
| Earnings (TTM) | -€3.48m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-2.6x
P/E RatioIs BONEH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BONEH income statement (TTM) | |
|---|---|
| Revenue | €0 |
| Cost of Revenue | €3.62k |
| Gross Profit | -€3.62k |
| Other Expenses | €3.48m |
| Earnings | -€3.48m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Aug 30, 2024
| Earnings per share (EPS) | -0.18 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 93.0% |
How did BONEH perform over the long term?
See historical performance and comparison